Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe: The HTLV European Research Network

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 1, 1996, Pages 68-77

  Taylor, Graham P ^a   Goubau, P ^b   Wantzin, P ^c   Gessain, A ^d   Jeannel, D ^d   Coste, J ^e   Pauli, G ^f   von der Helm, K ^g   Bertazzoni, U ^h   Casoli, C ⁱ   De Rossi, A ^j   Del Mistro, A ^j   Wicks, R ^k   Gabutti, G ^k   Saracco, A ^l   Varnier, O ^l   Huisman, J ^m   Avillez, F ⁿ   Gursevitch, V ^o   Horal, P ^p   Andersson, S ^q   Brewer, J ^r   Brennan, M ^s   Mortimer, P ^t   Tosswill, J ^t   Noone, A ^u   Patrick, H ^u   Weiss, R ^v   Weber, J ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c HVIDOVRE HOSPITAL   (Denmark)

^d INSTITUT PASTEUR   (France)

^e Centre Gui de Chauliac   (France)

^f AIDS Zentrum   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h CNR   (Italy)

ⁱ Department of Medicine and Surgery   (Italy)

^j VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^k Instituto di Igiene e Medicina Preventiva   (Italy)

^l SAN RAFFAELE HOSPITAL   (Italy)

^m CENTRAL LABORATORY   (Netherlands)

ⁿ NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^o Institute of Carcinogenesis   (Russian Federation)

^p UNIVERSITY OF GOTHENBURG   (Sweden)

^q SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^r ROYAL LONDON HOSPITAL   (United Kingdom)

^s North London Centre   (United Kingdom)

^t CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^u PUBLIC HEALTH ENGLAND   (United Kingdom)

^v INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

Antenatal; Blood transfusion; Europe; Human T cell leukaemia lymphoma viruses types I and II (HTLV I and II); Screening; Transmission

Indexed keywords

ARTICLE; EUROPE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SEXUAL TRANSMISSION; UNITED KINGDOM; VIRUS DIAGNOSIS;

HTLV; HTLV I; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029779602     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Shultz T, Weber J. Epidemiology of HTLV-I. In: Dalgliesh, Weiss, eds. AIDS and the new viruses. London: Academic Press, 1990:135-62.
2. Goubau P, Liu H-F, De Lange GG, Vandamme A-M, Desmyter J. HTLV-II seroprevalence in Pygmies across Africa since 1970. AIDS Res Human Retroviruses 1993;9:709-13.
3. Hall WW, Zhu SW, Horal P, Furuta Y, Zagaany G, Vahine A. HTLV-II infection in Mongolia. 6th International Conference on Human Retrovirology 1994. AIDS Res Human Retroviruses 1994;10:443 (abstract).
4. Gallo RC. The first human retrovirus. Sci Am 1986;255:78-88.
5. Gessain A, Barin F, Vernant J, et al. Antibodies to HTLV-I in patients with tropical spastic paraparesis. Lancet 1985;2: 1257.
6. Morgan OStC, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989;2: 1184-7.
7. Nishioka K, Maruyama I, Sato K, et al. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989:1:441.
8. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocytic alveolitis in HTLV-I associated myelopathy. Lancet 1987;2:1220.
9. Nakao K, Ohba N. Clinical features of HTLV-I associated uveitis. Br J Ophthalmol 1993;77:274-9.
10. Wyld PJ, Tosswill JH, Mortimer PP, Weber JN. Sporadic HTLV-I associated adult T-cell leukaemia (ATL) in the UK. Br J Haematol 1990;76:149-50.
11. Fanin R, Minutillo S, D'Agaro P, et al. HTLV-I positive adult T-cell leukaemia-lymphoma: a report of a typical case from Italy. Haematologica 1990;75:375-80.
12. Senjuta N, Pavlish O, Gurtsevitch V. Case of adult T-cell leukaemia in HTLV-I infected family in Georgia, USSR. Lancet 1991;338:1394.
13. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322: 383-7.
14. de Stasio G, Lattanzio A, Rizzi L, et al. HTLV-I infection is not endemic in Apulia (Southern Italy), Int J Cancer 1989; 44:1132-3.
15. Gradilone A, Zani M, Barillari G, et al. HTLV-I and HIV infection in drug addicts in Italy. Lancet 1986;2:653-4.
16. Henrard DR, Soriano V, Robertson E, et al. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. J Clin Microbiol 1995;33:1735-8.
17. Anonymous. AIDS. Proposed WHO criteria for interpreting results from Western Blot assay for HIV-1, HIV-2 and HTLV-I/II. Wkly Epidemiol Rec 1990;65:282-8.
18. Varnier OE, Lillo F, Alexander SS, Forbis RM, Present W, Lazzarin A. HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. JAMA 1991; 265:597.
19. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan J. Indeterminate HTLV serologic results in US blood donors: Are they due to HTLV-I or HTLV-II? J Acquir Immun Defic Syndr 1992;5:400-4.
20. Alexander S, Gallo D, Yamaguchi K, et al. Sensitivity and specificity analysis of the multicentre serum testing by the Kumamoto workshop group. 6th International Conference on Human Retrovirology 1994. AIDS Res Hum Retroviruses 1994;10:495 (abstract).
21. Kline RL, Brothers T, Halsey N, Boulos R, Lairmore MD, Quinn TC. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II. Lancet 1991;337:30-3.
22. Gallo D, Khashe S, Hoffman M. Comparison of sensitivity of two new commercial HTLV enzyme immunoassays for the detection of HTLV-I and HTLV-II antibody. 1st National Conference on Human Retrovirology and Related Infection, Washington, DC, Dec 1993.
23. Wiktor SZ, Pate EJ, Weiss SH, et al. Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet 1991;338:512-3.
24. Couroucé A-M, Pillonel J, Lemaire J-M, Maniez M, Brunet J-B. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 1993;7-:841-7.
25. Politis C, Economidou I, Fragatou S, et al. Prevalence of HTLV-I/II in blood donors and in multitransfused patients with thalassaemia and renal failure. Iatriki 1993;63:502-7.
26. Zaaijer HL, Cuypers HTM, Dudok de Wot C, Lelie PN. Results of 1 year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion 1994;34:877-80.
27. Mannella E, Miceli M, Di Lorenzo A, Podagrosi D, Mercurio G, Gallo A. Prevalenza delle infezioni da HTLV-I e HTLV-II in donatori di sangue. Gior Ital AIDS 1993;4:219-23.
28. Shih J, Senjuta N, Stepina V, Yakovleva L, Gursevitch V. HTLV seroprevalence in regions of the former USSR. Proceedings IX International Conference on AIDS, Berlin, June 1993:683.
29. Gursevitch V, Senjuta N, Stepina V, et al. HTLV-I family infection in Turkmenistan. Proceedings IX International Conference on AIDS, Berlin, June 1993:676.
30. Gurtsevitch V. Proceedings International Conference on AIDS, St. Petersberg, 1992:44.
31. Paun L, Ispas D, Del Mistro A, Chieco-Bianchi L. HTLV-I in Romania. Eur J Haematol 1994;52:117-8.
32. Brennan M, Runganga J, Barbara JAJ, et al. Prevalence of antibodies to human T-cell leukaemia/lymphoma virus in blood donors in north London. BMJ 1993;307:1235-9.
33. Courtois F, Barin F, Larsen M, Brassard Y, Masselin A, Engelman P. HTLV-I/II infection in pregnant women in Paris. Lancet 1990;335:1103.
34. Tosswill JHC, Ades AE, Peckham C, Mortimer P, Weber JN. Infection with human T-cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London. BMJ 1990;301:95-6.
35. Banatvala JE, Chrystie IL, Palmer SJ, Kenney A. Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet 1990;335:859-60.
36. Nightingale S, Orton D, Ratcliffe D, Skidmore S, Tosswill J, Desselberger U. Antenatal survey for the seroprevalence of HTLV-I infection in the West Midlands, England. Epidemiol Infect 1993;110:379-87.
37. van den Hoek JAR, Al EJM, Huisman JG, Goudsmit J, Coutinho RA. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands. J Med Virol 1991;34:100-3.
38. Calderón EJ, Gómez-Lucia E, Aguado I, Pineda JA, Essex M, Leal M. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain. Eur J Clin Microbiol 1991;10:773-5.
39. a Varela J, Rua-Figueroa M, et al. The presence of HTLV-I/II in non-intravenous drug using Spanish prostitutes. Int J Sex Transmit Dis AIDS 1992;3:62-3.
40. Nunnari A, Russo R, Cosentino S, et al. The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy. J Acquir Immune Defic Syndr 1992;5:211-3.
41. Mozzi F, Rebulla P, Lillo F, et al. HIV and HTLV infections in 1305 transfusion-dependent thalassemics in Italy. AIDS 1992;6:505-8.
42. Soriano V, Tor J, Ribera A, et al. HIV-1, HIV-2 and HTLV-I infection in high-risk groups in Spain. AIDS 1989; 3:615-6.
43. Copplestone J, Prentice A, Hamon M, Gawler J, Anderson N. HTLV-I infection is crippling. BMJ 1994;308:273.
44. Krook A, Blomberg J. HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994;26:129-32.
45. Coste J, Lemarie J, Couroucé A-M, the Retrovirus Study Group of the French Society of Blood Transfusion, Canavaggio M. Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. AIDS 1993;7:440-1.
46. Vignoli C, Zandotti C, De Lamballerie X, Tamalet C, Gastaut JA, De Micco Ph. Prevalence of HTLV-II and HIV-1-infected drug addicts in Marseille. Eur J Epidemiol 1993;9: 351-2.
47. De Rossi A, Mammano F, Del Mistro A, Chieco-Bianchi L. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction. Eur J Cancer 1991;7:835-8.
48. Calabró ML, Luparello M, Grottola A, et al. Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in Southeastern Italy. J Infect Dis 1993;168:1273-7.
49. Zella D, Mori L, Sala M, et al. HTLV-II infection in Italian drug users. Lancet 1990;336:575-6.
50. Padua E, Avillez F. Estudo de Prevaléncia da Infecçáo por HTLV-I. Rev Port Doenç Inf 1992;15:177-9.
51. Soriano V, Calderón E, Esparza B, et al. HTLV-I/II infections in Spain. Int J Epidemiol 1993;22:716-9.
52. Blomberg J, Moestrup T, Frimand J, et al. HTLV-I and -II in intravenous drug users from Sweden and Denmark. Scand J Infect Dis 1994;26:23-6.
53. Tosswill JH. Proceedings Vth International Conference Human Retrovirology, 1992.
54. Ando Y, Saito K, Nakano S, et al. Bottle-feeding can prevent transmission of HTLV-I from mothers to their babies. J Infect 1989;19:25-9.